| SC 13G/A | 2024-02-09 | FMR LLC | Foghorn Therapeutics Inc. | 2,810,009 | 6.7% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | Foghorn Therapeutics Inc. | 3,117,394 | 7.5% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | Foghorn Therapeutics Inc. | 2,484,834 | 6.7% | EDGAR |
| SC 13G | 2021-12-13 | ELI LILLY & Co | Foghorn Therapeutics Inc. | 4,000,000 | 9.7% | EDGAR |
| SC 13G | 2021-04-19 | KADOCH CIGALL | Foghorn Therapeutics Inc. | 3,957,712 | 11.0% | EDGAR |
| SC 13G | 2021-02-08 | FMR LLC | Foghorn Therapeutics Inc. | 2,580,634 | 7.0% | EDGAR |
| SC 13G | 2021-02-04 | Klarman Family Foundation | Foghorn Therapeutics Inc. | - | 6.0% | EDGAR |
| SC 13D | 2020-10-29 | Flagship Ventures Fund V, L.P. | Foghorn Therapeutics Inc. | 9,330,878 | 26.1% | EDGAR |